Rigel Pharmaceuticals Inc – Bilanz (NASDAQ:RIGL) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 110.38 M167.33 M134.28 M117.22 M163.98 M513.59 M Gesamtverbindlichkeiten 76.35 M136.95 M147.9 M145.87 M160.69 M122.11 M Gesamtkapital 34.03 M30.37 M-13.62 M-28.64 M3.29 M391.48 M Gesamtverbindlichkeiten und Eigenkapital 110.38 M167.33 M134.28 M117.22 M163.98 M513.59 M Gesamtverschuldung 19.82 M19.91 M39.45 M59.6 M59.68 M52.29 M Nettoverschuldung -37.51 M-105.05 M-18.76 M2.67 M-17.64 M-102.72 M

Nachrichten

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel meldet 60 % Jahreswachstum und vielversprechende Daten zu MDS/n

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Earnings Call Transkript: Rigel meldet robustes Wachstum für Q4 2025/n

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline